These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15221328)

  • 1. Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.
    Venkatraman MS; Chittiboyina A; Meingassner J; Ho CI; Varani J; Ellis CN; Avery MA; Pershadsingh HA; Kurtz TW; Benson SC
    Arch Dermatol Res; 2004 Aug; 296(3):97-104. PubMed ID: 15221328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
    Chittiboyina AG; Venkatraman MS; Mizuno CS; Desai PV; Patny A; Benson SC; Ho CI; Kurtz TW; Pershadsingh HA; Avery MA
    J Med Chem; 2006 Jul; 49(14):4072-84. PubMed ID: 16821769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
    Fang XK; Gao J; Zhu DN
    Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application.
    Bhagavathula N; Nerusu KC; Reddy M; Ellis CN; Chittiboyina A; Avery M; Pershadsingh HA; Kurtz TW; Varani J
    J Pharmacol Exp Ther; 2005 Dec; 315(3):996-1004. PubMed ID: 16109743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
    Rival Y; Stennevin A; Puech L; Rouquette A; Cathala C; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Wurch T; Junquéro D
    J Pharmacol Exp Ther; 2004 Nov; 311(2):467-75. PubMed ID: 15273253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
    Melagraki G; Afantitis A; Igglessi-Markopoulou O; Detsi A; Koufaki M; Kontogiorgis C; Hadjipavlou-Litina DJ
    Eur J Med Chem; 2009 Jul; 44(7):3020-6. PubMed ID: 19232783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
    Demerjian M; Man MQ; Choi EH; Brown BE; Crumrine D; Chang S; Mauro T; Elias PM; Feingold KR
    Exp Dermatol; 2006 Mar; 15(3):154-60. PubMed ID: 16480422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
    Murakami K; Bujo H; Unoki H; Saito Y
    Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
    He G; Muga S; Thuillier P; Lubet RA; Fischer SM
    Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.